Yasuo Arakawa

588 total citations
23 papers, 468 citations indexed

About

Yasuo Arakawa is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yasuo Arakawa has authored 23 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 8 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Yasuo Arakawa's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Yasuo Arakawa is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Yasuo Arakawa collaborates with scholars based in Japan and United States. Yasuo Arakawa's co-authors include Mitsuhiko Moriyama, Naohide Tanaka, Hiroshi Matsumura, Kazunori Kajino, Okio Hino, Hiroaki Yamagami, Kazushige Nirei, Hitomi Nakamura, Shunichi Matsuoka and J. Hayashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Clinical Neurophysiology.

In The Last Decade

Yasuo Arakawa

23 papers receiving 452 citations

Peers

Countries citing papers authored by Yasuo Arakawa

Since Specialization

Citations

This map shows the geographic impact of Yasuo Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Arakawa more than expected).

Fields of papers citing papers by Yasuo Arakawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Arakawa. The network helps show where Yasuo Arakawa may publish in the future.

Co-authorship network of co-authors of Yasuo Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Arakawa. A scholar is included among the top collaborators of Yasuo Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Arakawa. Yasuo Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Seven-Color TcMsEP Grading System: A Novel Alarm Method for Intraoperative Neurophysiological Monitoring Using Transcranial Electrical Stimulated Muscle Evoked Potentials (TcMsEPs) in Intramedullary Spinal Cord Tumor Surgeries 2020 ·Spine Surgery and Related Research ·Yasushi Fujiwara, (unknown), (unknown), Yasuo Arakawa, (unknown), Makoto Nishimori, (unknown), Nobuo Adachi	2
2	Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis 2017 ·International Journal of Medical Sciences ·(unknown), (unknown), Hiroshi Matsumura, Yasuo Arakawa, Hitomi Nakamura, Kazushige Nirei, Toshiki Yamamoto, Hiroaki Yamagami, Masahiro Ogawa, Takuji Gotoda, Shunichi Matsuoka, Noriko Nakajima, Masahiko Sugitani, Mitsuhiko Moriyama, Hiroshi Murayama	5
3	A novel procedure for imaging acute coronary syndrome lesions using frequency-domain optical coherence tomography 2013 ·EuroIntervention ·Yuji Yamaguchi, Eisuke Kagawa, Masaya Kato, Shota Sasaki, Yoshinori Nakano, (unknown), (unknown), Yasuo Arakawa, (unknown), Akira Ueda, Keigo Dote	2
4	Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C 2012 ·Journal of Clinical Biochemistry and Nutrition ·Hiroshi Matsumura, Kazushige Nirei, Hitomi Nakamura, Yasuo Arakawa, (unknown), (unknown), Hiroaki Yamagami, (unknown), Masahiro Ogawa, Noriko Nakajima, Naohide Tanaka, Mitsuhiko Moriyama	46
5	Expression of Intercellular Adhesion Molecule-1 in the Livers of Rats Treated with Diethylnitrosamine 2009 ·Journal of Clinical Biochemistry and Nutrition ·Shunichi Matsuoka, Hiroshi Matsumura, Yasuo Arakawa, Hitomi Nakamura, Kazushige Nirei, Hiroaki Yamagami, Masahiro Ogawa, Noriko Nakajima, (unknown), Naohide Tanaka, Mitsuhiko Moriyama	3
6	Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency 2009 ·International Journal of Laboratory Hematology ·Naoko Miwa, T. Akiba, Naoki Kimata, Yoshitaka Hamaguchi, Yasuo Arakawa, (unknown), Kosaku Nitta, K. Tsuchiya	44
7	Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. 2009 ·PubMed ·Shunichi Matsuoka, Hiroshi Matsumura, Hitomi Nakamura, (unknown), Yasuo Arakawa, J. Hayashi, (unknown), Kazushige Nirei, Hiroaki Yamagami, Masahiro Ogawa, Noriko Nakajima, (unknown), Naohide Tanaka, Mitsuhiko Moriyama	53
8	Influence of Occult Hepatitis B Virus Coinfection on the Incidence of Fibrosis and Hepatocellular Carcinoma in Chronic Hepatitis C 2008 ·Intervirology ·Shunichi Matsuoka, Kazushige Nirei, Akinori Tamura, Hitomi Nakamura, Hiroshi Matsumura, (unknown), Yasuo Arakawa, Hiroaki Yamagami, Naohide Tanaka, Mitsuhiko Moriyama	59
9	Factors Influencing Treatment Efficacy of 24-Week Combination Therapy with Interferon α-2b Plus Ribavirin for Chronic Hepatitis C 2007 ·Digestive Diseases and Sciences ·Mitsuhiko Moriyama, Hiroshi Matsumura, Kazushige Nirei, Yasuo Arakawa, Hiroaki Yamagami, Masahiro Ogawa, Miki Kaneko, (unknown), (unknown), Naohide Tanaka, Yasuyuki Arakawa	5
10	Interferon Therapy Improves the Irregular Regeneration of Hepatocytes in Liver in Patients with C-Viral Chronic Hepatitis and Liver Cirrhosis 2006 ·Intervirology ·Mitsuhiko Moriyama, Hiroshi Matsumura, (unknown), Hitomi Nakamura, Yasuo Arakawa, Kazushige Nirei, Hiroshi Aoki, Hiroaki Yamagami, Miki Kaneko, Naohide Tanaka, Yasuyuki Arakawa	6
11	Clinical Significance of Evaluation of Serum Zinc Concentrations in C-Viral Chronic Liver Disease 2006 ·Digestive Diseases and Sciences ·Mitsuhiko Moriyama, Hiroshi Matsumura, Akiko Fukushima, (unknown), Yasuo Arakawa, Kazushige Nirei, Hiroaki Yamagami, Miki Kaneko, Naohide Tanaka, Yasuyuki Arakawa	29
12	Measurement of Human Intercellular Adhesion Molecule 1 in the Blood Is Useful for Predicting the Occurrence of Hepatocellular Carcinomas from Chronic Hepatitis C and Liver Cirrhosis 2006 ·Intervirology ·Mitsuhiko Moriyama, Hiroshi Matsumura, (unknown), Hiroshi Aoki, Hitomi Nakamura, Yasuo Arakawa, Kazushige Nirei, Hiroaki Yamagami, Miki Kaneko, Naohide Tanaka, Yasuyuki Arakawa	9
13	Full Genomic Analysis of Hepatitis Delta Virus Prevalent on Miyako Island, Japan 2005 ·Intervirology ·Mitsuhiko Moriyama, (unknown), Hiroshi Matsumura, Hiroshi Aoki, Yasuo Arakawa, Miki Kaneko, (unknown), Naohide Tanaka, Yasuyuki Arakawa	2
14	Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis 2004 ·Biochemical and Biophysical Research Communications ·Yasuo Arakawa, Kazunori Kajino, (unknown), Hiroshi Tobita, J. Hayashi, (unknown), Mitsuhiko Moriyama, Yasuyuki Arakawa, Okio Hino	38
15	PBC-AIH overlap syndrome with concomitant ITP and Hashimoto?s disease with positivity for anti-centromere antibody 2004 ·Journal of Gastroenterology ·(unknown), Yasuo Arakawa, (unknown), Hiroshi Miyakawa, (unknown), Naohide Tanaka, Mitsuhiko Moriyama, (unknown), Masahiko Sugitani, Yasuyuki Arakawa	11
16	Isotypes of rheumatoid factors in rheumatoid arthritis and chronic liver diseases 2002 ·Modern Rheumatology ·Mari Kaneko, Susumu Nishinarita, (unknown), Y. Tomita, Yoshihiro Matsukawa, Shigeki Sawada, (unknown), Naohide Tanaka, Yasuo Arakawa	1
17	Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma 2002 ·Journal of Gastroenterology ·Okio Hino, Kazunori Kajino, (unknown), Yasuo Arakawa	44
18	Blinded, prospective, and serial evaluation by quantitative-EEG in interferon-alpha-treated hepatitis-C 1999 ·Acta Neurologica Scandinavica ·Satoshi Kamei, Naohide Tanaka, (unknown), Yasuo Arakawa, Tetsuhito Kojima, Yoshihiro Matsukawa, T Takasu, Mitsuhiko Moriyama	19
19	[C-type hepatitis in spontaneous intracerebral hemorrhage]. 1996 ·PubMed ·(unknown), T Watanabe, Takayoshi Koike, Yasuo Arakawa	8
20	Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal. 1996 ·Proceedings of the National Academy of Sciences ·Hiroshi Aoki, Kazunori Kajino, Yasuo Arakawa, Okio Hino	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact